Merck CEO: COVID-19 vaccine manufacture and distribution ‘huge issue’ 15-Jul-2020 By Ben Hargreaves Kenneth Frazier states manufacture of potential vaccine is ‘bigger challenge’ than developing an effective vaccine.
Takeda deal looks to bolster biologics pipeline 14-Jul-2020 By Ben Hargreaves Takeda partners with Twist Bioscience for access to platform to discover, validate and optimize antibodies in its pipeline.
Dewpoint and Merck in $305m deal for HIV ‘cure’ 14-Jul-2020 By Ben Hargreaves The two partners will use Dewpoint’s platform, focusing on biomolecular condensates, to treat the disease.
Webinar delves into drug delivery innovations 09-Jul-2020 By Jenni Spinner Innovations in Drug Delivery Part II, a free online event on July 15, will feature novel technologies and innovative solutions to current challenges.
Rentschler and Vetter cooperate to integrate services 09-Jul-2020 By Ben Hargreaves The CDMOs will launch pilot projects to determine where collaboration may help streamline drug development.
Operation Warp Speed delivers $2bn to scale COVID-19 solutions 08-Jul-2020 By Ben Hargreaves Novavax is the principle recipient of the funding, as US government provides capital in return for guaranteed access to doses.
Regeneron COVID-19 antibody cocktail enters late-stage trials 07-Jul-2020 By Ben Hargreaves Regeneron’s potential coronavirus treatment enters Phase III and US government provides capital injection for manufacture.
Sarepta licenses therapy to boost gene therapies 06-Jul-2020 By Ben Hargreaves Sarepta signs agreement with Hansa to use its treatment as part of a gene therapy treatment schedule.
Pfizer posts positive vaccine results and capacity for 1.2bn doses 02-Jul-2020 By Ben Hargreaves Pfizer and BioNTech release positive results from Phase I/II trials investigating their mRNA vaccine against COVID-19.
Inovio posts positive COVID-19 vaccine results but few details 30-Jun-2020 By Ben Hargreaves The biotech reveals positive results of Phase I trials but does not provide a fuller picture of data.
Stevanato partners with CEPI for 2 billion vaccine vials 29-Jun-2020 By Ben Hargreaves CEPI signs agreement for supply of glass vials to speed up COVID-19 vaccine development timeline.
Moderna secures fill-finish capabilities for COVID-19 vaccine 29-Jun-2020 By Ben Hargreaves Moderna signs deal with Catalent for fill-finish services, shortly after AZ announced the same move.
WHO seeks $31bn in next 18 months to combat COVID-19 29-Jun-2020 By Ben Hargreaves The organization wants to raise the sum to support its ‘three pillar’ approach to the pandemic: vaccines, therapeutics, and diagnostics.
Cytiva expands Massachusetts biomanufacturing site 25-Jun-2020 By Ben Hargreaves The facility has been expanded to cater to the growing number of small- to mid-size biotechs looking to contract manufacture.
AstraZeneca makes another vaccine supply agreement 25-Jun-2020 By Ben Hargreaves AZ enters a supply agreement with Symbiosis as it continues to work on bolstering supply for its COVID-19 vaccine.
